MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukaemia but can be preferentially targeted by the MDM2 inhibitor Nutlin-3a Posted byadmin 27. July 2020 Tinhofer, I, Gryshchenko, I, Stoecher, M, Hofbauer, S, Daniel, PT, Greil, R